Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Factorial study of achievement related motives.
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.
CDC Sexually Transmitted Infections Treatment Guidelines, 2021.
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Chronic pain and driving: proceed with caution.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Salgia, Ravi
One or more keywords matched the following items that are connected to
Salgia, Ravi
Item Type
Name
Concept
Xenograft Model Antitumor Assays
Academic Article
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Academic Article
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Academic Article
Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.
Academic Article
Overexpression of the ยต-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
Academic Article
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.
Academic Article
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article
EphB4 as a therapeutic target in mesothelioma.
Academic Article
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
Academic Article
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Academic Article
AXL mediates resistance to cetuximab therapy.
Academic Article
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Academic Article
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Academic Article
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Academic Article
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Academic Article
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article
2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
Academic Article
Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
Academic Article
RLIP inhibition suppresses breast-to-lung metastasis.
Academic Article
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Academic Article
Targeting RLIP with CRISPR/Cas9 controls tumor growth.
Academic Article
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.
Academic Article
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.
Academic Article
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Search Criteria
Xenograft Model Antitumor Assays